Newmont Corp (Symbol: NEM) has been named as a Top 5 dividend paying metals and mining stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted…
Pharvaris announces positive deucrictibant data indicating safety and efficacy for hereditary angioedema treatment and potential expansion.Quiver AI SummaryPharvaris has announced promising data regarding deucrictibant, a novel oral bradykinin B2 receptor…
SAIC reports $1.88 billion in revenues, 2% growth, and reaffirms fiscal year 2026 guidance amid evolving technology demands.Quiver AI SummaryScience Applications International Corporation (SAIC) reported a revenue of $1.88 billion…
Codere Online Luxembourg filed its 2024 annual report, regaining compliance with Nasdaq rules, pending final confirmation.Quiver AI SummaryCodere Online Luxembourg, S.A., a prominent online gaming operator in Spain and Latin…
BioNTech and Bristol Myers Squibb announced a collaboration to co-develop the bispecific antibody BNT327 for solid tumors.Quiver AI SummaryBioNTech and Bristol Myers Squibb have announced a partnership for the global…
Brazil Potash reports key achievements in governance, construction, and financing for its Autazes Potash Project ahead of June conference.Quiver AI SummaryBrazil Potash Corp. has made significant progress in 2025 toward…
Castellum, Inc. CEO Glen Ives will present at the 2025 Virtual Tech Conference from June 3rd to 5th.Quiver AI SummaryCastellum, Inc. announced that CEO Glen Ives will present at the…
Piedmont Office Realty Trust announces significant second quarter leasing success and participation in Nareit REITWeek Investor Conference in NYC.Quiver AI SummaryPiedmont Office Realty Trust, Inc. announced its participation in the…
Liquidia announces FDA approval and commercial launch of YUTREPIA for treating pulmonary arterial hypertension and PH-ILD.Quiver AI SummaryLiquidia Corporation has announced that its inhalation powder YUTREPIA™ (treprostinil) is now available…
Atacicept met its primary endpoint in the ORIGIN Phase 3 trial, significantly reducing proteinuria in IgAN patients.Quiver AI SummaryVera Therapeutics, Inc. announced that its ORIGIN Phase 3 trial for atacicept,…
Hyperscale Data sells minority interest in a pharmaceutical company for $4.65 million, focusing on data center expansion in Michigan.Quiver AI SummaryHyperscale Data, Inc. announced the sale of its minority equity…
Soybeans were under pressure again on Friday, with contracts down 10 to 12 cents. July gave back 18 ½ cents this week, as November was down 23 ¾ cents. The…